Researchers identify two drugs that delay bone marrow cancer development
Study finds racial equity in crisis standard of care guidelines
22 March 2021Hitting the reset button: Building a better normal after the pandemic
22 March 2021Researchers identify two drugs that delay bone marrow cancer development
Primary myelofibrosis (PMF), a relatively rare but painful type of bone marrow cancer, disrupts the body’s normal production of blood cells by causing extensive scarring in the bone marrow. Regrettably, few treatment options are available, with most of them being palliative in nature. The only curative treatment is a stem cell transplant, for which few patients are eligible.
